Direct Keap 1-Nrf2 disruption as a potential therapeutic target for Alzheimer's disease

COUNTER-compliant statistics provided by IRUS-UK.
Unless otherwise indicated, items in Spiral are protected by copyright and are licensed under a Creative Commons Attribution NonCommercial NoDerivatives License.